Antithrombotic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S193000

Reexamination Certificate

active

06924296

ABSTRACT:
This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

REFERENCES:
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/00126 (1999-01-01), None
patent: WO 99/00127 (1999-01-01), None
patent: WO 99/00128 (1999-01-01), None
patent: WO 00/39092 (2000-07-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 00/39118 (2000-07-01), None
patent: WO 02/10154 (2002-02-01), None
Wyngaarden et al. “Cecil Textbook of medicine” Saunders, p. 247-248, 1005-1006 (1983).
McCarthy et al. preparation of substituted diamine . . . CA 131:310284 (1999).
Vacca, Joseph P. (Annette M. Doherty Section Editor), Annual Reports in Medicinal Chemistry, (1998), 33, 81-90.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antithrombotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antithrombotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombotic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3504008

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.